The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Optic Nerve Glioma-Global Market Insights and Sales Trends 2024
Synopsis
An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the optic chiasm, where the left and right optic nerves cross. They are also referred to as optic glioma or juvenile pilocytic astrocytoma. Optic nerve glioma is a rare kind of cancer that’s typically slow growing and found in children. It is rarely found in individuals over the age of 20. It has also been associated with the genetic disorder neurofibromatosis type 1, or NF1.
The global Optic Nerve Glioma market size is expected to reach US$ 392.2 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Optic Nerve Glioma in various end use industries. The expanding demands from the Hospitals & Clinics, Diagnostic Centers and Others,, are propelling Optic Nerve Glioma market. Neurological Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Computed Tomography (CT) segment is estimated at % CAGR for the next seven-year period.
Treatment for these cancers is best done by a multidisciplinary treatment team. Surgery and radiation therapy are two possible ways of treating optic nerve glioma. Surgery may be performed if doctors believe they can use it to completely remove the tumor. Alternately, if the tumor is not completely removable, surgeons may remove parts of it to help relieve pressure in the skull. Radiation therapy can be done before surgery to shrink the tumor before doctors it. Alternately, it may be done after surgery to kill any remaining cancer cells. Radiation therapy involves using a machine to aim high-energy rays at the site of the tumor. Chemotherapy uses medications to kill cancer cells. This is particularly useful if the cancer has spread to other parts of the brain. Corticosteroids may be administered to reduce swelling in the skull.
Report Objectives
This report provides market insight on the different segments, by players, by Diagnosis, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Optic Nerve Glioma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Optic Nerve Glioma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Optic Nerve Glioma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Optic Nerve Glioma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Optic Nerve Glioma covered in this report include Biocompare, Bio-Rad Laboratories, Miltenyi Biotec, BioLegend, Becton, Dickinson And Company, Beckman Coulter, Merck, ImmunoReagents and Thermo Fisher Scientific, etc.
The global Optic Nerve Glioma market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific
Global Optic Nerve Glioma market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Optic Nerve Glioma market, Segment by Diagnosis:
Neurological Exam
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Biopsy
Global Optic Nerve Glioma market, by Application
Hospitals & Clinics
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Diagnosis, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Optic Nerve Glioma companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the optic chiasm, where the left and right optic nerves cross. They are also referred to as optic glioma or juvenile pilocytic astrocytoma. Optic nerve glioma is a rare kind of cancer that’s typically slow growing and found in children. It is rarely found in individuals over the age of 20. It has also been associated with the genetic disorder neurofibromatosis type 1, or NF1.
The global Optic Nerve Glioma market size is expected to reach US$ 392.2 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Optic Nerve Glioma in various end use industries. The expanding demands from the Hospitals & Clinics, Diagnostic Centers and Others,, are propelling Optic Nerve Glioma market. Neurological Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Computed Tomography (CT) segment is estimated at % CAGR for the next seven-year period.
Treatment for these cancers is best done by a multidisciplinary treatment team. Surgery and radiation therapy are two possible ways of treating optic nerve glioma. Surgery may be performed if doctors believe they can use it to completely remove the tumor. Alternately, if the tumor is not completely removable, surgeons may remove parts of it to help relieve pressure in the skull. Radiation therapy can be done before surgery to shrink the tumor before doctors it. Alternately, it may be done after surgery to kill any remaining cancer cells. Radiation therapy involves using a machine to aim high-energy rays at the site of the tumor. Chemotherapy uses medications to kill cancer cells. This is particularly useful if the cancer has spread to other parts of the brain. Corticosteroids may be administered to reduce swelling in the skull.
Report Objectives
This report provides market insight on the different segments, by players, by Diagnosis, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Optic Nerve Glioma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Optic Nerve Glioma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Optic Nerve Glioma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Optic Nerve Glioma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Optic Nerve Glioma covered in this report include Biocompare, Bio-Rad Laboratories, Miltenyi Biotec, BioLegend, Becton, Dickinson And Company, Beckman Coulter, Merck, ImmunoReagents and Thermo Fisher Scientific, etc.
The global Optic Nerve Glioma market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific
Global Optic Nerve Glioma market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Optic Nerve Glioma market, Segment by Diagnosis:
Neurological Exam
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Biopsy
Global Optic Nerve Glioma market, by Application
Hospitals & Clinics
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Diagnosis, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Optic Nerve Glioma companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Optic Nerve Glioma
1.1 Optic Nerve Glioma Market Overview
1.1.1 Optic Nerve Glioma Product Scope
1.1.2 Optic Nerve Glioma Market Status and Outlook
1.2 Global Optic Nerve Glioma Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Optic Nerve Glioma Market Size by Region (2018-2029)
1.4 Global Optic Nerve Glioma Historic Market Size by Region (2018-2023)
1.5 Global Optic Nerve Glioma Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Optic Nerve Glioma Market Size (2018-2029)
1.6.1 North America Optic Nerve Glioma Market Size (2018-2029)
1.6.2 Europe Optic Nerve Glioma Market Size (2018-2029)
1.6.3 Asia-Pacific Optic Nerve Glioma Market Size (2018-2029)
1.6.4 Latin America Optic Nerve Glioma Market Size (2018-2029)
1.6.5 Middle East & Africa Optic Nerve Glioma Market Size (2018-2029)
2 Optic Nerve Glioma Market by Diagnosis
2.1 Introduction
2.1.1 Neurological Exam
2.1.2 Computed Tomography (CT)
2.1.3 Magnetic Resonance Imaging (MRI)
2.1.4 Biopsy
2.2 Global Optic Nerve Glioma Market Size by Diagnosis: 2018 VS 2022 VS 2029
2.2.1 Global Optic Nerve Glioma Historic Market Size by Diagnosis (2018-2023)
2.2.2 Global Optic Nerve Glioma Forecasted Market Size by Diagnosis (2024-2029)
2.3 Key Regions Market Size by Diagnosis
2.3.1 North America Optic Nerve Glioma Revenue Breakdown by Diagnosis (2018-2029)
2.3.2 Europe Optic Nerve Glioma Revenue Breakdown by Diagnosis (2018-2029)
2.3.3 Asia-Pacific Optic Nerve Glioma Revenue Breakdown by Diagnosis (2018-2029)
2.3.4 Latin America Optic Nerve Glioma Revenue Breakdown by Diagnosis (2018-2029)
2.3.5 Middle East and Africa Optic Nerve Glioma Revenue Breakdown by Diagnosis (2018-2029)
3 Optic Nerve Glioma Market Overview by Application
3.1 Introduction
3.1.1 Hospitals & Clinics
3.1.2 Diagnostic Centers
3.1.3 Others
3.2 Global Optic Nerve Glioma Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Optic Nerve Glioma Historic Market Size by Application (2018-2023)
3.2.2 Global Optic Nerve Glioma Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Optic Nerve Glioma Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Optic Nerve Glioma Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Optic Nerve Glioma Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Optic Nerve Glioma Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Optic Nerve Glioma Revenue Breakdown by Application (2018-2029)
4 Optic Nerve Glioma Competition Analysis by Players
4.1 Global Optic Nerve Glioma Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Optic Nerve Glioma as of 2022)
4.3 Date of Key Players Enter into Optic Nerve Glioma Market
4.4 Global Top Players Optic Nerve Glioma Headquarters and Area Served
4.5 Key Players Optic Nerve Glioma Product Solution and Service
4.6 Competitive Status
4.6.1 Optic Nerve Glioma Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biocompare
5.1.1 Biocompare Profile
5.1.2 Biocompare Main Business
5.1.3 Biocompare Optic Nerve Glioma Products, Services and Solutions
5.1.4 Biocompare Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.1.5 Biocompare Recent Developments
5.2 Bio-Rad Laboratories
5.2.1 Bio-Rad Laboratories Profile
5.2.2 Bio-Rad Laboratories Main Business
5.2.3 Bio-Rad Laboratories Optic Nerve Glioma Products, Services and Solutions
5.2.4 Bio-Rad Laboratories Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories Recent Developments
5.3 Miltenyi Biotec
5.3.1 Miltenyi Biotec Profile
5.3.2 Miltenyi Biotec Main Business
5.3.3 Miltenyi Biotec Optic Nerve Glioma Products, Services and Solutions
5.3.4 Miltenyi Biotec Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.3.5 BioLegend Recent Developments
5.4 BioLegend
5.4.1 BioLegend Profile
5.4.2 BioLegend Main Business
5.4.3 BioLegend Optic Nerve Glioma Products, Services and Solutions
5.4.4 BioLegend Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.4.5 BioLegend Recent Developments
5.5 Becton, Dickinson And Company
5.5.1 Becton, Dickinson And Company Profile
5.5.2 Becton, Dickinson And Company Main Business
5.5.3 Becton, Dickinson And Company Optic Nerve Glioma Products, Services and Solutions
5.5.4 Becton, Dickinson And Company Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.5.5 Becton, Dickinson And Company Recent Developments
5.6 Beckman Coulter
5.6.1 Beckman Coulter Profile
5.6.2 Beckman Coulter Main Business
5.6.3 Beckman Coulter Optic Nerve Glioma Products, Services and Solutions
5.6.4 Beckman Coulter Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.6.5 Beckman Coulter Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Optic Nerve Glioma Products, Services and Solutions
5.7.4 Merck Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 ImmunoReagents
5.8.1 ImmunoReagents Profile
5.8.2 ImmunoReagents Main Business
5.8.3 ImmunoReagents Optic Nerve Glioma Products, Services and Solutions
5.8.4 ImmunoReagents Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.8.5 ImmunoReagents Recent Developments
5.9 Thermo Fisher Scientific
5.9.1 Thermo Fisher Scientific Profile
5.9.2 Thermo Fisher Scientific Main Business
5.9.3 Thermo Fisher Scientific Optic Nerve Glioma Products, Services and Solutions
5.9.4 Thermo Fisher Scientific Optic Nerve Glioma Revenue (US$ Million) & (2018-2023)
5.9.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Optic Nerve Glioma Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Optic Nerve Glioma Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Optic Nerve Glioma Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Optic Nerve Glioma Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Optic Nerve Glioma Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Optic Nerve Glioma Market Dynamics
11.1 Optic Nerve Glioma Industry Trends
11.2 Optic Nerve Glioma Market Drivers
11.3 Optic Nerve Glioma Market Challenges
11.4 Optic Nerve Glioma Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
